Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors.
about
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours.Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenograftsCamptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
type
label
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
prefLabel
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
P2093
P1476
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
P2093
A H Gelderblom
A S Planting
A Sparreboom
B K Dallaire
D J Wagener
L W van Maanen
M E van der Burg
M J de Jonge
P304
P356
10.1200/JCO.1999.17.7.2219
P407
P577
1999-07-01T00:00:00Z